Johnson & Johnson Pursues FDA Approval for Groundbreaking wAIHA Treatment with IMAAVY® Johnson & Johnson has submitted a new drug application to the FDA seeking to make IMAAVY® the first-ever approved treatment for warm autoimmune hemolytic anemia (wAIHA), a serious disease.

Johnson & Johnson Pursues FDA Approval for Groundbreaking wAIHA Treatment with IMAAVY® #United_States #Johnson_&_Johnson #Spring_House #IMAAVY #wAIHA

Waiha Market Size, Share & Global Industry Report 2035 The Waiha Market will grow from USD 34.45 billion in 2024 to USD 53.49 billion by 2035, CAGR 4.08%.

🌍⚕️ WAIHA Market insights & trends 👉 www.marketresearchfuture.com/reports/waih... #GlobalHealthcare #WAIHA #HealthIndustry

High Health Care Use and Treatment Heterogeneity in wAIHA High health care resource use and inconsistent rituximab dosing practices highlight the need for standardized wAIHA treatment guidelines.

The current standard of care for warm autoimmune hemolytic anemia (#wAIHA) requires significant use of health care resources, according to results presented at the 2025 @ash.hematology.org (ASH) Annual Meeting.

Read more: https://bit.ly/4p25dWq

#RareDisease #Hematology

The liveliest poster session ever! #ASH25 #Orlando #wAIHA #Rilzabrurinib #Medsky #Hemesky

Florida’s natural beauty is stunning, but the state government continues to create danger for medically vulnerable children and adults. Overturning vaccine mandates makes no sense. #vaccineswork #autoimmunedisease #autoimmunity #waiha #coldagglutinindisease #lupus #autoimmunehemolyticanemia